Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 12.6f

Immunosuppression Use for Maintenance by Regimen

One Year Following Transplantation, 1997 to 2006

Recipients with Lung Transplants

  Transplant Year
1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
Transplants 948 893 922 977 1,083 1,054 1,099 1,185 1,407 1,406
Functioning Graft at 1 Year PostTx 673 631 668 735 805 833 899 988 1,132 1,157
With Maintenance Use Recorded at 1 Year PostTx 88 325 621 695 767 809 868 979 1,118 1,141
CyA 0.0% 0.0% 0.0% 0.4% 0.0% 0.1% 0.0% 0.0% 0.0% 0.2%
Tac 0.0% 0.3% 0.2% 0.0% 0.3% 0.6% 0.3% 0.1% 0.0% 0.2%
--- + MMF/MPA 0.0% 0.3% 0.3% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.2%
CyA + MMF/MPA 1.1% 0.0% 0.0% 0.1% 0.4% 0.1% 0.3% 0.0% 0.1% 0.2%
Tac + MMF/MPA 0.0% 0.6% 0.3% 1.3% 0.5% 1.0% 0.5% 0.4% 0.5% 1.2%
--- + OtherAntimet 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0%
CyA + OtherAntimet 0.0% 0.3% 0.2% 0.1% 0.1% 0.4% 0.2% 0.0% 0.0% 0.1%
Tac + OtherAntimet 0.0% 0.0% 0.2% 0.1% 0.1% 1.2% 0.5% 0.2% 0.1% 0.2%
CyA + MMF/MPA + OtherAntimet 0.0% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Tac + MMF/MPA + OtherAntimet 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1%
--- + Siro/Evero 0.0% 0.0% 0.3% 0.0% 0.3% 0.1% 0.1% 0.0% 0.0% 0.0%
CyA + Siro/Evero 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1%
Tac + Siro/Evero 0.0% 0.0% 0.2% 0.1% 0.1% 0.2% 0.1% 0.0% 0.1% 0.1%
--- + MMF/MPA + Siro/Evero 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.0% 0.0% 0.1% 0.0%
Tac + MMF/MPA + Siro/Evero 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.0% 0.1% 0.1%
--- + OtherAntimet + Siro/Evero 0.0% 0.0% 0.0% 0.0% 0.0% 0.2% 0.0% 0.0% 0.0% 0.0%
Tac + OtherAntimet + Siro/Evero 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.0% 0.0%
--- + Steroids 3.4% 0.9% 0.5% 0.4% 0.5% 0.4% 0.7% 0.4% 0.4% 0.5%
CyA + Steroids 6.8% 4.3% 5.6% 3.5% 2.1% 1.6% 2.3% 1.1% 1.3% 1.5%
Tac + Steroids 2.3% 5.5% 6.4% 5.5% 9.9% 7.3% 8.2% 9.9% 9.6% 8.5%
--- + MMF/MPA + Steroids 0.0% 0.3% 0.0% 0.4% 0.3% 0.1% 0.3% 0.2% 0.2% 0.5%
CyA + MMF/MPA + Steroids 17.0% 15.4% 17.4% 14.0% 14.0% 10.8% 8.9% 7.6% 7.6% 4.1%
Tac + MMF/MPA + Steroids 18.2% 17.5% 17.2% 26.6% 29.7% 32.6% 34.1% 41.0% 45.9% 47.5%
--- + OtherAntimet + Steroids 1.1% 0.3% 0.2% 0.4% 0.3% 0.2% 0.3% 0.1% 0.1% 0.5%
CyA + OtherAntimet + Steroids 30.7% 32.3% 26.7% 22.9% 12.4% 8.2% 8.8% 6.2% 4.9% 4.6%
Tac + OtherAntimet + Steroids 10.2% 18.2% 17.4% 16.3% 17.3% 20.1% 22.8% 22.9% 20.4% 22.0%
--- + Siro/Evero + Steroids 0.0% 0.0% 0.0% 0.0% 0.1% 0.7% 0.2% 0.2% 0.4% 0.1%
CyA + Siro/Evero + Steroids 0.0% 0.3% 1.8% 1.3% 0.9% 0.9% 0.5% 0.3% 0.1% 0.4%
Tac + Siro/Evero + Steroids 0.0% 0.0% 3.2% 2.7% 3.5% 6.3% 4.0% 4.2% 3.8% 3.4%
Other Regimen 9.1% 3.4% 1.9% 3.5% 7.0% 6.6% 6.5% 5.1% 4.5% 3.8%


Source: OPTN/SRTR Data as of May 1, 2008.

Percentages are calculated based on the total number of patients with maintenance use at one year following transplantation. They sum to 100 percent for each column.

---: No Calcineurin Inhibitor Use; CyA: Cyclosporine; Tac: Tacrolimus.

MMF: Mycophenolate Mofetil; MPA: Mycophenolate Sodium; Siro: Sirolimus; Evero: Everolimus; OtherAntimet: Antimetabolites excluding MMF and MPA.

"Other Regimen" includes drug combinations that are different from the listed regimens and drugs from the text field entering.



PDF FormatRequires Adobe Acrobat Reader